Investigation of Vascular Relaxing Effects of the Antidiabetic Rosiglitazone.

NCT00154011 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: rosiglitazone (drug)

Sponsor

Technische Universität Dresden